{"id":"https://openalex.org/W2901468849","doi":"https://doi.org/10.1177/2045894018816294","title":"Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real\u2010world US database","display_name":"Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real\u2010world US database","publication_year":2018,"publication_date":"2018-11-13","ids":{"openalex":"https://openalex.org/W2901468849","doi":"https://doi.org/10.1177/2045894018816294","mag":"2901468849","pmid":"https://pubmed.ncbi.nlm.nih.gov/30421652","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6432690"},"language":"en","primary_location":{"id":"doi:10.1177/2045894018816294","doi":"https://doi.org/10.1177/2045894018816294","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2045894018816294","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2045894018816294","source":{"id":"https://openalex.org/S2764573606","display_name":"Pulmonary Circulation","issn_l":"2045-8932","issn":["2045-8932","2045-8940"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Circulation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2045894018816294","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005007256","display_name":"Sean M. Studer","orcid":"https://orcid.org/0000-0001-9273-392X","observed_orcids":["https://orcid.org/0000-0001-9273-392X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean Studer","raw_affiliation_strings":["NYC Health + Hospitals/Kings County, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYC Health + Hospitals/Kings County, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023459185","display_name":"MICHAEL L. HULL","orcid":"https://orcid.org/0000-0002-0947-0776","observed_orcids":["https://orcid.org/0000-0002-0947-0776"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Hull","raw_affiliation_strings":["Optum, Eden Prairie, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum, Eden Prairie, MN, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018840280","display_name":"Janis Pruett","orcid":"https://orcid.org/0000-0003-1434-0244","observed_orcids":["https://orcid.org/0000-0003-1434-0244"]},"institutions":[{"id":"https://openalex.org/I4210094322","display_name":"Actelion (United States)","ror":"https://ror.org/00qjbvq93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094322","https://openalex.org/I95056601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janis Pruett","raw_affiliation_strings":["Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210094322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088923735","display_name":"Eleena Koep","orcid":"https://orcid.org/0000-0003-4002-996X","observed_orcids":["https://orcid.org/0000-0003-4002-996X"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleena Koep","raw_affiliation_strings":["Optum, Eden Prairie, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum, Eden Prairie, MN, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110558199","display_name":"Yuen Tsang","orcid":"https://orcid.org/0009-0008-4991-9356","observed_orcids":["https://orcid.org/0009-0008-4991-9356"]},"institutions":[{"id":"https://openalex.org/I4210094322","display_name":"Actelion (United States)","ror":"https://ror.org/00qjbvq93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094322","https://openalex.org/I95056601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuen Tsang","raw_affiliation_strings":["Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210094322"]}]},{"author_position":"last","author":{"id":null,"display_name":"William Drake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094322","display_name":"Actelion (United States)","ror":"https://ror.org/00qjbvq93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094322","https://openalex.org/I95056601"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Drake","raw_affiliation_strings":["Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210094322"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023459185"],"corresponding_institution_ids":["https://openalex.org/I4210124242"],"apc_list":{"value":2310,"currency":"USD","value_usd":2310},"apc_paid":{"value":2310,"currency":"USD","value_usd":2310},"fwci":2.6553,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.89880374,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"1","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":1.0},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9879999756813049},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.8529999852180481},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9570000171661377},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8980000019073486},{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/newly-diagnosed-patients","display_name":"newly diagnosed patients","score":0.7369999885559082},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9480150938034058},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7716068029403687},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7627137899398804},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.6767181754112244},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5304669141769409},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5122172236442566},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4981038570404053},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4756336212158203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45031124353408813},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3401721715927124},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.06669792532920837},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/2045894018816294","doi":"https://doi.org/10.1177/2045894018816294","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2045894018816294","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2045894018816294","source":{"id":"https://openalex.org/S2764573606","display_name":"Pulmonary Circulation","issn_l":"2045-8932","issn":["2045-8932","2045-8940"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Circulation","raw_type":"journal-article"},{"id":"pmid:30421652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30421652","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary circulation","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6432690","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6432690/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulm Circ","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:f55acd6d11874dc9ba9c3f921129fd57","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f55acd6d11874dc9ba9c3f921129fd57","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pulmonary Circulation, Vol 9 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/2045894018816294","doi":"https://doi.org/10.1177/2045894018816294","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2045894018816294","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1177/2045894018816294","source":{"id":"https://openalex.org/S2764573606","display_name":"Pulmonary Circulation","issn_l":"2045-8932","issn":["2045-8932","2045-8940"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320338282","display_name":"Actelion Pharmaceuticals","ror":"https://ror.org/001yedb91"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2901468849.pdf","grobid_xml":"https://content.openalex.org/works/W2901468849.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1825951622","https://openalex.org/W1963993684","https://openalex.org/W1977983100","https://openalex.org/W1988399640","https://openalex.org/W1990905820","https://openalex.org/W2003005123","https://openalex.org/W2014175051","https://openalex.org/W2022046816","https://openalex.org/W2026939372","https://openalex.org/W2028086898","https://openalex.org/W2029154296","https://openalex.org/W2034227629","https://openalex.org/W2035384054","https://openalex.org/W2090878184","https://openalex.org/W2095956343","https://openalex.org/W2106446798","https://openalex.org/W2112229901","https://openalex.org/W2116088357","https://openalex.org/W2124586765","https://openalex.org/W2132843316","https://openalex.org/W2139062201","https://openalex.org/W2139437349","https://openalex.org/W2139954704","https://openalex.org/W2146177859","https://openalex.org/W2158862125","https://openalex.org/W2161370807","https://openalex.org/W2162572028","https://openalex.org/W2175995520","https://openalex.org/W2183644045","https://openalex.org/W2184111926","https://openalex.org/W2202160722","https://openalex.org/W2278696749","https://openalex.org/W2288033263","https://openalex.org/W2300167479","https://openalex.org/W2324452947","https://openalex.org/W2492714460","https://openalex.org/W2520374352","https://openalex.org/W2555019470","https://openalex.org/W2582602949","https://openalex.org/W2613438200","https://openalex.org/W2740590067","https://openalex.org/W2779746431","https://openalex.org/W2786532587","https://openalex.org/W2944748045"],"related_works":["https://openalex.org/W2980372397","https://openalex.org/W2995779757","https://openalex.org/W4229000027","https://openalex.org/W2786532587","https://openalex.org/W4315796545","https://openalex.org/W4414031713","https://openalex.org/W2972316344","https://openalex.org/W2955033565","https://openalex.org/W7122843714","https://openalex.org/W2162572028"],"abstract_inverted_index":{"Several":[0],"new":[1],"medications":[2],"for":[3,55,67],"pulmonary":[4],"arterial":[5],"hypertension":[6],"(PAH)":[7],"have":[8],"recently":[9],"been":[10],"introduced;":[11],"however,":[12],"current":[13],"real-world":[14],"data":[15],"regarding":[16],"US":[17,49],"patients":[18,42,142,152,211],"with":[19,43,116,120,178,194,214,226],"PAH":[20,32,46,56],"are":[21],"limited.":[22],"We":[23],"conducted":[24],"a":[25,237],"retrospective":[26],"administrative":[27],"claims":[28],"study":[29,192],"to":[30,61,206,247],"examine":[31],"treatment":[33,72,115],"patterns":[34],"and":[35,39,77,91,118,173,183,222,235],"summarize":[36],"healthcare":[37,74],"utilization":[38,187],"costs":[40,78,195],"among":[41],"newly":[44,53],"diagnosed":[45],"treated":[47,54,213],"in":[48,196,236],"clinical":[50,245],"practice.":[51],"Patients":[52],"from":[57,204],"1":[58],"January":[59],"2010":[60],"31":[62],"March":[63],"2015":[64],"were":[65,79,99,176,212],"followed":[66],"\u226512":[68],"months.":[69],"Patient":[70],"characteristics,":[71],"patterns,":[73],"resource":[75],"utilization,":[76],"described.":[80],"Adherence":[81],"(proportion":[82],"of":[83,94,136,140,165,210,240],"days":[84],"covered),":[85],"persistence":[86],"(months":[87],"until":[88],"therapy":[89,157,199],"discontinuation/modification),":[90],"the":[92,96,149,166,191,197],"probability":[93],"continuing":[95],"index":[97,102,126,146,167],"regimen":[98,103,127,147,231],"analyzed":[100],"by":[101],"cohort":[104,200],"(monotherapy":[105],"versus":[106],"combination":[107,121,156,174,198,220],"therapy).":[108],"Of":[109],"1637":[110],"eligible":[111],"patients,":[112,241],"93.8%":[113],"initiated":[114],"monotherapy":[117,134],"6.2%":[119],"therapy.":[122],"The":[123,208],"most":[124],"common":[125],"was":[128,188],"phosphodiesterase":[129],"type":[130],"5":[131],"inhibitor":[132],"(PDE-5I)":[133],"(70.0%":[135],"patients).":[137],"A":[138],"total":[139],"581":[141],"(35.5%)":[143],"modified":[144],"their":[145],"during":[148],"study.":[150],"Most":[151],"(55.4%)":[153],"who":[154],"began":[155],"did":[158],"so":[159],"on":[160],"or":[161],"within":[162],"six":[163],"months":[164],"date.":[168],"Endothelin":[169],"receptor":[170],"agonists":[171],"(ERAs)":[172],"therapies":[175,221],"associated":[177,225],"higher":[179,227],"adherence":[180],"than":[181,202],"PDE-5Is":[182],"monotherapies,":[184],"respectively.":[185],"Healthcare":[186],"substantial":[189,238],"across":[190],"population,":[193],"more":[201],"doubling":[203],"baseline":[205],"follow-up.":[207],"majority":[209],"monotherapies":[215,248],"(most":[216],"often,":[217],"PDE-5Is),":[218],"despite":[219],"ERAs":[223],"being":[224],"medication":[228],"adherence.":[229],"Index":[230],"adjustments":[232],"occurred":[233],"early":[234],"proportion":[239],"suggesting":[242],"that":[243],"inadequate":[244],"response":[246],"may":[249],"not":[250],"be":[251],"uncommon.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2018-11-29T00:00:00"}